Literature DB >> 16369376

The HIV-1 Non-subtype B Workgroup: an international collaboration for the collection and analysis of HIV-1 non-subtype B data.

Rami Kantor1, Robert W Shafer, David Katzenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16369376      PMCID： PMC1681398     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  11 in total

1.  Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries.

Authors:  R W Shafer; D R Jung; B J Betts
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

2.  HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms.

Authors:  Jaideep Ravela; Bradley J Betts; Francoise Brun-Vézinet; Anne-Mieke Vandamme; Diane Descamps; Kristel van Laethem; Kate Smith; Jonathan M Schapiro; Dean L Winslow; Caroline Reid; Robert W Shafer
Journal:  J Acquir Immune Defic Syndr       Date:  2003-05-01       Impact factor: 3.731

3.  Drug resistance mutations in HIV-1.

Authors:  Richard T D'Aquila; Jonathan M Schapiro; Françoise Brun-Vézinet; Bonaventura Clotet; Brian Conway; Lisa M Demeter; Robert M Grant; Victoria A Johnson; Daniel R Kuritzkes; Clive Loveday; Robert W Shafer; Douglas D Richman
Journal:  Top HIV Med       Date:  2003 May-Jun

4.  HIV drug resistance.

Authors:  François Clavel; Allan J Hance
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

5.  A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors.

Authors:  Bluma Brenner; Dan Turner; Maureen Oliveira; Daniela Moisi; Mervi Detorio; Mauricio Carobene; Richard G Marlink; Jonathan Schapiro; Michel Roger; Mark A Wainberg
Journal:  AIDS       Date:  2003-01-03       Impact factor: 4.177

6.  Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

Authors:  Jean-Luc Meynard; Muriel Vray; Laurence Morand-Joubert; Esther Race; Diane Descamps; Gilles Peytavin; Sophie Matheron; Claire Lamotte; Sonia Guiramand; Dominique Costagliola; Françoise Brun-Vézinet; François Clavel; Pierre-Marie Girard
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

7.  Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000.

Authors:  Saladin Osmanov; Claire Pattou; Neff Walker; Bernhard Schwardländer; Jose Esparza
Journal:  J Acquir Immune Defic Syndr       Date:  2002-02-01       Impact factor: 3.731

8.  Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance.

Authors:  Paul J Weidle; Samuel Malamba; Raymond Mwebaze; Catherine Sozi; Gideon Rukundo; Robert Downing; Debra Hanson; Dorothy Ochola; Peter Mugyenyi; Jonathan Mermin; Badara Samb; Eve Lackritz
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

9.  Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance.

Authors:  Ana T Dumans; Marcelo A Soares; Elizabeth S Machado; Stéphane Hué; Rodrigo M Brindeiro; Deenan Pillay; Amilcar Tanuri
Journal:  J Infect Dis       Date:  2004-03-12       Impact factor: 5.226

10.  Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial.

Authors:  Deenan Pillay; A Sarah Walker; Diana M Gibb; Anita de Rossi; Steve Kaye; Mounir Ait-Khaled; Maria Muñoz-Fernandez; Abdel Babiker
Journal:  J Infect Dis       Date:  2002-08-09       Impact factor: 5.226
View more
  4 in total

1.  Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.

Authors:  Maria Mercedes Santoro; Claudia Alteri; Luigi Ronga; Philippe Flandre; Lavinia Fabeni; Fabio Mercurio; Roberta D'Arrigo; Caterina Gori; Guido Palamara; Ada Bertoli; Federica Forbici; Romina Salpini; Evangelo Boumis; Valerio Tozzi; Ubaldo Visco-Comandini; Mauro Zaccarelli; Margriet Van Houtte; Theresa Pattery; Pasquale Narciso; Andrea Antinori; Francesca Ceccherini-Silberstein; Carlo Federico Perno
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-18       Impact factor: 2.205

2.  Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility.

Authors:  Jamie L Kear; Mandy E Blackburn; Angelo M Veloro; Ben M Dunn; Gail E Fanucci
Journal:  J Am Chem Soc       Date:  2009-10-21       Impact factor: 15.419

3.  Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs.

Authors:  Mark A Wainberg; Bluma G Brenner
Journal:  Viruses       Date:  2010-11-11       Impact factor: 5.048

4.  The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs.

Authors:  Mark A Wainberg; Bluma G Brenner
Journal:  Mol Biol Int       Date:  2012-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.